BLUM ROBERT Idirector, officer: President & CEOdirector, officer: President & ..
Common Stock
5,000
$0.58
$2,900
Option
MORGANS DAVID J JRofficer: EVP-Preclinical R&Dofficer: EVP-Preclinical R&D
Common Stock
5,000
$1.2
$6,000
Option
BLUM ROBERT Idirector, officer: President & CEOdirector, officer: President & ..
Incentive Stock Option (right to buy)
5,000
$0.58
$2,900
Sale
MORGANS DAVID J JRofficer: EVP-Preclinical R&Dofficer: EVP-Preclinical R&D
Common Stock
5,000
$1.2
$6,000
Sale
TRAUTMAN JAY Kofficer: VP, Discovery Researchofficer: VP, Discovery Research
Common Stock
1,000
$7.29
$7,290
Sale
SABRY JAMES Hother: Former Executive Chairmanother: Former Executive Chairman
Common Stock
7,000
$0.58
$4,060
Option
SABRY JAMES Hother: Former Executive Chairmanother: Former Executive Chairman
Non-Qualified Stock Option (right to buy)
7,000
$0.58
$4,060
Option
SABRY JAMES Hother: Former Executive Chairmanother: Former Executive Chairman
Common Stock
7,000
$0.58
$4,060
Option
BLUM ROBERT Idirector, officer: President & CEOdirector, officer: President & ..
Common Stock
5,000
$0.58
$2,900
Option
BLUM ROBERT Idirector, officer: President & CEOdirector, officer: President & ..
Incentive Stock Option (right to buy)
5,000
$0.58
$2,900
Sale
BLUM ROBERT Idirector, officer: President & CEOdirector, officer: President & ..
Common Stock
5,000
$7.01
$35,065
Sale
SPUDICH JAMES Adirectordirector
Common Stock
2,200
$7.02
$15,433
Sale
TRAUTMAN JAY Kofficer: VP, Discovery Researchofficer: VP, Discovery Research
Common Stock
1,000
$7
$7,000
Option
BLUM ROBERT Idirector, officer: President & CEOdirector, officer: President & ..
Incentive Stock Option (right to buy)
5,000
$0.58
$2,900
Sale
BLUM ROBERT Idirector, officer: President & CEOdirector, officer: President & ..
Common Stock
5,000
$6.81
$34,045
Option
BLUM ROBERT Idirector, officer: President & CEOdirector, officer: President & ..
Common Stock
5,000
$0.58
$2,900
Sale
MORGANS DAVID J JRofficer: EVP-Preclinical R&Dofficer: EVP-Preclinical R&D
Common Stock
5,000
$1.2
$6,000
Option
MORGANS DAVID J JRofficer: EVP-Preclinical R&Dofficer: EVP-Preclinical R&D
Incentive Stock Option (right to buy)
5,000
$1.2
$6,000
Option
MORGANS DAVID J JRofficer: EVP-Preclinical R&Dofficer: EVP-Preclinical R&D
Common Stock
5,000
$1.2
$6,000
Option
SABRY JAMES Hother: Former Executive Chairmanother: Former Executive Chairman
Common Stock
7,000
$0.58
$4,060
Option
BLUM ROBERT Idirector, officer: President & CEOdirector, officer: President & ..
Incentive Stock Option (right to buy)
5,000
$0.58
$2,900
Sale
BLUM ROBERT Idirector, officer: President & CEOdirector, officer: President & ..
Common Stock
5,000
$6.4
$31,980
Option
SABRY JAMES Hother: Former Executive Chairmanother: Former Executive Chairman
Non-Qualified Stock Option (right to buy)
7,000
$0.58
$4,060
Sale
SABRY JAMES Hother: Former Executive Chairmanother: Former Executive Chairman
Common Stock
7,000
$6.44
$45,080
Option
BLUM ROBERT Idirector, officer: President & CEOdirector, officer: President & ..
Common Stock
5,000
$0.58
$2,900
Sale
SPUDICH JAMES Adirectordirector
Common Stock
2,200
$6.49
$14,267
Option
MORGANS DAVID J JRofficer: EVP-Preclinical R&Dofficer: EVP-Preclinical R&D
Incentive Stock Option (right to buy)
5,000
$1.2
$6,000
Sale
BLUM ROBERT Idirector, officer: President & CEOdirector, officer: President & ..
Common Stock
5,000
$6.77
$33,830
Sale
MORGANS DAVID J JRofficer: EVP-Preclinical R&Dofficer: EVP-Preclinical R&D
Common Stock
5,000
$1.2
$6,000
Option
BLUM ROBERT Idirector, officer: President & CEOdirector, officer: President & ..
Incentive Stock Option (right to buy)
5,000
$0.58
$2,900
Option
MORGANS DAVID J JRofficer: EVP-Preclinical R&Dofficer: EVP-Preclinical R&D
Common Stock
5,000
$1.2
$6,000
Option
BLUM ROBERT Idirector, officer: President & CEOdirector, officer: President & ..
Common Stock
5,000
$0.58
$2,900
Sale
TRAUTMAN JAY Kofficer: VP, Discovery Researchofficer: VP, Discovery Research
Common Stock
1,000
$7
$7,000
Option
SABRY JAMES Hother: Former Executive Chairmanother: Former Executive Chairman
Non-Qualified Stock Option (right to buy)
7,000
$0.58
$4,060
Option
SABRY JAMES Hother: Former Executive Chairmanother: Former Executive Chairman
Common Stock
7,000
$0.58
$4,060
Sale
SABRY JAMES Hother: Former Executive Chairmanother: Former Executive Chairman
Common Stock
7,000
$6.8
$47,586
Sale
BLUM ROBERT Idirector, officer: President & CEOdirector, officer: President & ..
Common Stock
5,000
$0.58
$2,900
Option
BLUM ROBERT Idirector, officer: President & CEOdirector, officer: President & ..
Common Stock
5,000
$0.58
$2,900
Option
BLUM ROBERT Idirector, officer: President & CEOdirector, officer: President & ..
Incentive Stock Option (right to buy)
5,000
$0.58
$2,900
Sale
SPUDICH JAMES Adirectordirector
Common Stock
2,200
$6.07
$13,361
Option
MORGANS DAVID J JRofficer: EVP-Preclinical R&Dofficer: EVP-Preclinical R&D
Incentive Stock Option (right to buy)
5,000
$1.2
$6,000
Option
MORGANS DAVID J JRofficer: EVP-Preclinical R&Dofficer: EVP-Preclinical R&D
Common Stock
5,000
$1.2
$6,000
Sale
MORGANS DAVID J JRofficer: EVP-Preclinical R&Dofficer: EVP-Preclinical R&D
Common Stock
5,000
$1.2
$6,000
Option
BLUM ROBERT Idirector, officer: President & CEOdirector, officer: President & ..
Incentive Stock Option (right to buy)
4,999
$0.58
$2,899
Sale
BLUM ROBERT Idirector, officer: President & CEOdirector, officer: President & ..
Common Stock
4,999
$5.45
$27,260
Option
BLUM ROBERT Idirector, officer: President & CEOdirector, officer: President & ..
Common Stock
4,999
$0.58
$2,899
Sale
SABRY JAMES Hother: Former Executive Chairmanother: Former Executive Chairman
Common Stock
7,000
$5.86
$40,985
Option
SABRY JAMES Hother: Former Executive Chairmanother: Former Executive Chairman
Common Stock
7,000
$0.58
$4,060
Option
SABRY JAMES Hother: Former Executive Chairmanother: Former Executive Chairman
Non-Qualified Stock Option (right to buy)
7,000
$0.58
$4,060
Option
BLUM ROBERT Idirector, officer: President & CEOdirector, officer: President & ..
Incentive Stock Option (right to buy)
4,999
$0.58
$2,899
Showing 1100 to 1150 of 1267 results.
Insider trading
Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.
Who is insider?
Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.